Aptar Pharma to Showcase Key Innovations and Connected Device Solutions at CPhI 2017

Aptar Pharma, a leading global solution provider of innovative drug delivery systems, is pleased to once again attend CPhI Worldwide from October 24 – 26 in Frankfurt, Germany. At booth 42F10, Aptar Pharma will highlight their wide product portfolio and their latest innovations addressing important healthcare technology megatrends. A dedicated innovation corner with a special connectivity hub will center on the growing field of connected healthcare solutions.

In addition to exhibiting at CPhI Worldwide, Aptar Pharma will present three Pharma Insight Briefings that will highlight the latest innovations and developments in the following drug delivery system areas:

  • Guenter Nadler, Director Business Development, will present “Innovative Respiratory Solutions for Expanding Your Product Portfolio“, an insightful talk on innovative respiratory solutions, on October 24 at 10:30 at the Innopack Zone, G1A3.
  • Sai Shankar, Director Business Development- Connected Services, will present “Driving Better Patient Outcomes with Connectivity” on October 24 at 15:50 at the Innopack Zone, G1A3. This briefing will focus on connected health and how Aptar Pharma supports Pharma companies worldwide with custom-made connected technology solutions for the treatment of respiratory diseases including Asthma and COPD.
  • Arnaud Fournier, Senior Business Project Manager for Injectables, will present “Setting New Standards for Coated Stoppers” on October 25 at 10:30 at the Innopack Zone, G1A3, where he will introduce PremiumCoat™, a coated stopper with an unrivaled, market-leading reduction in particulates.

Visit the Aptar Pharma booth, where their team of experts will be on hand to present their extensive product portfolio covering a broad range of therapeutic expertise.

Take a tour of Aptar Pharma’s innovation wall, discover their dedicated connectivity hub, and find out how Aptar Pharma continues to break new ground in innovative healthcare technologies.

For further information, please download our full Press Release.

Media Contacts:

Carolyn Penot

Aptar Pharma

+33 1 39 17 20 38



Marion Baschet Vernet

Press Attaché

+33 6 22 17 08 96